Alerts will be sent to your verified email
Verify Email
SANOFI
|
Sanofi India
|
FDC
|
Strides Pharma Scien
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
Domestic Sales Growth - YoY
|
1.7 % | 5.1 % | n/a |
|
Unclassified
|
|||
|
R&D as a % of Total Sales
|
0.0 | 2.22 % | 1.84 % |
|
Financials
|
|||
|
5 yr Average ROE
|
50.34 % | 12.9 % | 30.1 % |
|
5yr average Equity Multiplier
|
5.32 | 1.57 | 2.62 |
|
5yr Average Asset Turnover Ratio
|
0.42 | 0.55 | 0.6 |
|
5yr Avg Net Profit Margin
|
22.84 % | 15.2 % | 12.9 % |
|
Price to Book
|
10.33 | 2.68 | 3.21 |
|
P/E
|
24.98 | 23.67 | 17.95 |
|
5yr Avg Cash Conversion Cycle
|
-15.2 Days | -13.89 Days | -51.45 Days |
|
Inventory Days
|
67.68 Days | 61.89 Days | 69.05 Days |
|
Days Receivable
|
35.69 Days | 18.98 Days | 60.35 Days |
|
Days Payable
|
75.12 Days | 89.17 Days | 225.58 Days |
|
5yr Average Interest Coverage Ratio
|
777.41 | 90.41 | 0.72 |
|
5yr Avg ROCE
|
23.73 % | 13.8 % | 10.5 % |
|
5yr Avg Operating Profit Margin
|
25.16 % | 17.7 % | 12.17 % |
|
5 yr average Debt to Equity
|
0.0 | 0.0 | 1.01 |
|
5yr CAGR Net Profit
|
25.59 % | -2.41 % | 68.01 % |
|
5yr Average Return on Assets
|
9.68 % | 8.22 % | 10.97 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
60.4 % | 69.66 % | 27.91 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 27.27 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.16 % | -0.36 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.27 % | -1.8 % | -2.58 % |
|
Sanofi India
|
FDC
|
Strides Pharma Scien
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|